These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35967878)

  • 41. In vitro and in vivo trypanocidal activity of a benzofuroxan derivative against Trypanosoma cruzi.
    Dos Santos Petry L; Pillar Mayer JC; de Giacommeti M; Teixeira de Oliveira D; Razia Garzon L; Martiele Engelmann A; Magalhães de Matos AFI; Dellaméa Baldissera M; Dornelles L; Melazzo de Andrade C; Gonzalez Monteiro S
    Exp Parasitol; 2021; 226-227():108125. PubMed ID: 34129877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pentamidine antagonizes the benznidazole's effect in vitro, and lacks of synergy in vivo: Implications about the polyamine transport as an anti-Trypanosoma cruzi target.
    Seguel V; Castro L; Reigada C; Cortes L; Díaz MV; Miranda MR; Pereira CA; Lapier M; Campos-Estrada C; Morello A; Kemmerling U; Maya JD; López-Muñoz R
    Exp Parasitol; 2016 Dec; 171():23-32. PubMed ID: 27729250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of levamisole in co-administration with benznidazole on experimental Chagas disease.
    Rocha Simões-Silva M; Brandão Peres R; Britto C; Machado Cascabulho C; de Melo Oliveira G; Nefertiti da Gama A; França da Silva C; Lima da Costa K; Finamore Araújo P; Diego de Souza Campos J; Meuser Batista M; Cristina Demarque K; da Cruz Moreira O; de Nazaré Correia Soeiro M
    Parasitology; 2019 Jul; 146(8):1055-1062. PubMed ID: 31046850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of a combined treatment with a therapeutic vaccine and benznidazole for the Trypanosoma cruzi chronic infection.
    Prochetto E; Bontempi I; Rodeles L; Cabrera G; Vicco M; Cacik P; Pacini MF; Pérez Gianeselli M; Pérez AR; Marcipar I
    Acta Trop; 2022 May; 229():106334. PubMed ID: 35101415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
    Fernández MC; González Cappa SM; Solana ME
    Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.
    Caldas IS; Talvani A; Caldas S; Carneiro CM; de Lana M; da Matta Guedes PM; Bahia MT
    Parasitol Res; 2008 Jul; 103(2):413-21. PubMed ID: 18454349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
    Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD8low T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers.
    Marins-Dos-Santos A; Olivieri BP; Ferreira-Reis R; de Meis J; Silva AA; de Araújo-Jorge TC; Lannes-Vieira J; Cotta-de-Almeida V
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008969. PubMed ID: 33347472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in
    Barbosa JMC; Pedra-Rezende Y; Pereira LD; de Melo TG; Barbosa HS; Lannes-Vieira J; de Castro SL; Daliry A; Salomão K
    Front Cell Infect Microbiol; 2022; 12():975931. PubMed ID: 36093188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination Therapy Using Benznidazole and Aspirin during the Acute Phase of Experimental Chagas Disease Prevents Cardiovascular Dysfunction and Decreases Typical Cardiac Lesions in the Chronic Phase.
    Pereira RS; Malvezi AD; Lovo-Martins MI; Lucchetti BFC; Santos JP; Tavares ER; Verri WA; de Almeida Araújo EJ; Yamauchi LM; Yamada-Ogatta SF; Martins-Pinge MC; Pinge-Filho P
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue.
    Vilar-Pereira G; Castaño Barrios L; Silva AAD; Martins Batista A; Resende Pereira I; Cruz Moreira O; Britto C; Mata Dos Santos HA; Lannes-Vieira J
    PLoS One; 2021; 16(1):e0244710. PubMed ID: 33400707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unveiling benznidazole's mechanism of action through overexpression of DNA repair proteins in Trypanosoma cruzi.
    Rajão MA; Furtado C; Alves CL; Passos-Silva DG; de Moura MB; Schamber-Reis BL; Kunrath-Lima M; Zuma AA; Vieira-da-Rocha JP; Garcia JB; Mendes IC; Pena SD; Macedo AM; Franco GR; de Souza-Pinto NC; de Medeiros MH; Cruz AK; Motta MC; Teixeira SM; Machado CR
    Environ Mol Mutagen; 2014 May; 55(4):309-21. PubMed ID: 24347026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
    Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
    Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination therapy with benznidazole and doxycycline shows no additive effect to monotherapy with benznidazole in mice infected with the VL-10 strain of the Trypanosoma cruzi.
    Carneiro ACA; Costa GP; Ferreira CS; Ramos IPR; Sarandy MM; Leite ALJ; Menezes APJ; Silva BM; Nogueira KOPC; Carvalho ACC; Gonçalves RV; Talvani A
    Int J Cardiol; 2020 Jan; 299():243-248. PubMed ID: 31353153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
    Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
    Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene expression study using real-time PCR identifies an NTR gene as a major marker of resistance to benzonidazole in Trypanosoma cruzi.
    Mejía-Jaramillo AM; Fernández GJ; Palacio L; Triana-Chávez O
    Parasit Vectors; 2011 Sep; 4():169. PubMed ID: 21892937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069.
    Sayé M; Gauna L; Valera-Vera E; Reigada C; Miranda MR; Pereira CA
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007481. PubMed ID: 31961864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro trypanocidal activity of tetraethylthiuram disulfide and sodium diethylamine-N-carbodithioate on Trypanosoma cruzi.
    Lane JE; Ribeiro-Rodrigues R; Suarez CC; Bogitsh BJ; Jones MM; Singh PK; Carter CE
    Am J Trop Med Hyg; 1996 Sep; 55(3):263-6. PubMed ID: 8842112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mapping benznidazole resistance in trypanosomatids and exploring evolutionary histories of nitroreductases and ABCG transporter protein sequences.
    Petravicius PO; Costa-Martins AG; Silva MN; Reis-Cunha JL; Bartholomeu DC; Teixeira MMG; Zingales B
    Acta Trop; 2019 Dec; 200():105161. PubMed ID: 31494121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.